4-2827682-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001122681.2(SH3BP2):​c.586+8G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0812 in 1,569,274 control chromosomes in the GnomAD database, including 7,286 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.13 ( 1940 hom., cov: 34)
Exomes 𝑓: 0.076 ( 5346 hom. )

Consequence

SH3BP2
NM_001122681.2 splice_region, intron

Scores

2
Splicing: ADA: 0.001347
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.26

Publications

5 publications found
Variant links:
Genes affected
SH3BP2 (HGNC:10825): (SH3 domain binding protein 2) The protein encoded by this gene has an N-terminal pleckstrin homology (PH) domain, an SH3-binding proline-rich region, and a C-terminal SH2 domain. The protein binds to the SH3 domains of several proteins including the ABL1 and SYK protein tyrosine kinases , and functions as a cytoplasmic adaptor protein to positively regulate transcriptional activity in T, natural killer (NK), and basophilic cells. Mutations in this gene result in cherubism. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]
SH3BP2 Gene-Disease associations (from GenCC):
  • cherubism
    Inheritance: AD Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 4-2827682-G-A is Benign according to our data. Variant chr4-2827682-G-A is described in ClinVar as [Benign]. Clinvar id is 258897.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.27 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SH3BP2NM_001122681.2 linkc.586+8G>A splice_region_variant, intron_variant Intron 7 of 12 ENST00000503393.8 NP_001116153.1 P78314-1A0A384N6E5
SH3BP2NM_001145856.2 linkc.757+8G>A splice_region_variant, intron_variant Intron 7 of 12 NP_001139328.1 P78314-4
SH3BP2NM_001145855.2 linkc.670+8G>A splice_region_variant, intron_variant Intron 7 of 12 NP_001139327.1 P78314-3
SH3BP2NM_003023.4 linkc.586+8G>A splice_region_variant, intron_variant Intron 7 of 12 NP_003014.3 P78314-1A0A384N6E5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SH3BP2ENST00000503393.8 linkc.586+8G>A splice_region_variant, intron_variant Intron 7 of 12 1 NM_001122681.2 ENSP00000422168.3 P78314-1

Frequencies

GnomAD3 genomes
AF:
0.127
AC:
19268
AN:
152106
Hom.:
1933
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.275
Gnomad AMI
AF:
0.0559
Gnomad AMR
AF:
0.123
Gnomad ASJ
AF:
0.0741
Gnomad EAS
AF:
0.0572
Gnomad SAS
AF:
0.112
Gnomad FIN
AF:
0.0182
Gnomad MID
AF:
0.0854
Gnomad NFE
AF:
0.0651
Gnomad OTH
AF:
0.110
GnomAD2 exomes
AF:
0.0964
AC:
17727
AN:
183976
AF XY:
0.0929
show subpopulations
Gnomad AFR exome
AF:
0.294
Gnomad AMR exome
AF:
0.148
Gnomad ASJ exome
AF:
0.0645
Gnomad EAS exome
AF:
0.0651
Gnomad FIN exome
AF:
0.0181
Gnomad NFE exome
AF:
0.0694
Gnomad OTH exome
AF:
0.0924
GnomAD4 exome
AF:
0.0763
AC:
108100
AN:
1417050
Hom.:
5346
Cov.:
35
AF XY:
0.0763
AC XY:
53551
AN XY:
701474
show subpopulations
African (AFR)
AF:
0.287
AC:
9385
AN:
32662
American (AMR)
AF:
0.140
AC:
5473
AN:
38964
Ashkenazi Jewish (ASJ)
AF:
0.0635
AC:
1610
AN:
25354
East Asian (EAS)
AF:
0.0584
AC:
2206
AN:
37802
South Asian (SAS)
AF:
0.114
AC:
9244
AN:
81062
European-Finnish (FIN)
AF:
0.0198
AC:
1002
AN:
50630
Middle Eastern (MID)
AF:
0.107
AC:
611
AN:
5706
European-Non Finnish (NFE)
AF:
0.0677
AC:
73510
AN:
1086208
Other (OTH)
AF:
0.0862
AC:
5059
AN:
58662
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.578
Heterozygous variant carriers
0
4021
8043
12064
16086
20107
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2988
5976
8964
11952
14940
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.127
AC:
19303
AN:
152224
Hom.:
1940
Cov.:
34
AF XY:
0.124
AC XY:
9226
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.274
AC:
11390
AN:
41496
American (AMR)
AF:
0.124
AC:
1891
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0741
AC:
257
AN:
3468
East Asian (EAS)
AF:
0.0574
AC:
297
AN:
5178
South Asian (SAS)
AF:
0.113
AC:
544
AN:
4826
European-Finnish (FIN)
AF:
0.0182
AC:
193
AN:
10620
Middle Eastern (MID)
AF:
0.0850
AC:
25
AN:
294
European-Non Finnish (NFE)
AF:
0.0651
AC:
4425
AN:
68012
Other (OTH)
AF:
0.109
AC:
230
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
806
1611
2417
3222
4028
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
208
416
624
832
1040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0696
Hom.:
317
Bravo
AF:
0.141
Asia WGS
AF:
0.107
AC:
375
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 15, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Fibrous dysplasia of jaw Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
11
DANN
Benign
0.60
PhyloP100
1.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.0013
dbscSNV1_RF
Benign
0.024
SpliceAI score (max)
0.14
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28516876; hg19: chr4-2829409; API